Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
exv10w22
 

EXHIBIT 10.22
(PATHEON LOGO)
MASTER AGREEMENT FOR PHARMACEUTICAL DEVELOPMENT SERVICES
 
                 
1.
  Parties:       Patheon Pharmaceuticals Inc. (“Patheon”)   Orexigen Therapeutics Inc. (“Client”)
 
          2110 East Galbraith Road   28202 Cabot Road, Suite 200
 
          Cincinnati, Ohio 45237   Laguna Neguel, CA 92677
             
2.
  Projects:       Patheon may agree from time to time to perform the pharmaceutical development services for the Client described in a Project Proposal duly completed and executed by Patheon and the Client in the form attached hereto as Schedule B.
 
           
3.
  Contract:       Upon execution of a Project Proposal by Patheon and the Client, this agreement together with the Project Proposal (including the Project Scope and Budget Summary) shall be a contract binding on the parties (“Contract”).
 
           
4.
  Legal Terms:       The Terms and Conditions attached hereto as Schedule A shall apply to each Project.
 
           
5.
  Date of Confidentiality Agreement:       August 24, 2005
 
           
6.
  Date of Patheon PartnerTM External User Account/Account Form       , 200 [If applicable]
 
           
7.
  Date       February 16, 2007
                             
Patheon Pharmaceuticals Inc.       Orexigen Therapeutics Inc.
 
By:
  /s/ Edward W. Huber       By:   /s/ Anthony McKinney            
 
                           
Name:
  Edward W. Huber       Name:   Anthony McKinney            
Title:
  Acting Group Director, PDS       Title:   Chief Operating Officer            
CONFIDENTIAL